Net Net Stock Overview

Subscribe

To see hundreds more international net nets, consider subscribing

Overview

NanoVibronix Inc
Healthcare
P/NCAV
0.35x
Ticker
NAOV
Exchange
NASDAQ
Country
United States
Close
0.77 $
Mkt Cap
1.3M $
EV
-1.9M $
NCAV Burn Rate
-28.3%
Current Ratio
2.64
Debt/Equity
0.0
EV/REV
-0.85x
EV/EBIT
0.6x
EV/FCF
0.5x
Dilution
82.5% p.A
Total Net Income
-51.0M $
Cheapness
83.0%
NanoVibronix, Inc. is a medical device company. The Company is focused on developing noninvasive biological response-activating devices utilizing its low-intensity surface acoustic wave (SAW) technology. Its primary products consist of UroShield and PainShield. UroShield is an ultrasound-based product that is designed to prevent bacterial colonization and biofilm in urinary catheters, increase antibiotic efficacy and decrease pain and discomfort associated with urinary catheter use, which markets in the United States under Food and Drug Administration (FDA) policy of enforcement discretion during the COVID-19 pandemic and is undergoing clinical testing. PainShield is a patch-based therapeutic ultrasound technology to treat pain, muscle spasm and joint contractures by delivering a localized ultrasound effect to treat pain and induce soft tissue healing in a targeted area. Its PainShield family of products includes PainShield MD and PainShield Plus.

Profitability

positive values --- Average negative values

Margins

--- Average

Valuation

positive values --- Average negative values

Dilution

--- Average